| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |